Fundraising Fox

Innocrin Pharmaceuticals Holdings

Durham, US · Founded 2014 · Delaware LLC · 1 known investors

Biotech

Founders & leadership

RK
Richard KentDirector
KW
Kristopher WoodDirector
TL
Thomas LaundonExecutive Officer
SE
S. Edward TorresDirector
SW
Steven WeinsteinDirector
WM
William MooreExecutive Officer, Director
AV
Andrew von EschenbachDirector
RS
Robert SchotzingerDirector
DR
Douglas ReedDirector
FE
Fred EshelmanDirector

Investors · 1

Eshelman Ventures, LLCreportedWilmingtonvia Fred Eshelman · board

Reported raises · per SEC filings

Form D private placements
▶$6MraisedJul 2017 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kristopher WoodDirector
  • Charles OsborneExecutive Officer
  • S. Edward TorresDirector
  • Fred EshelmanExecutive Officer, Director
  • Andrew von EschenbachDirector
  • Douglas ReedDirector
  • Robert SchotzingerDirector
  • Richard KentDirector
Offering amount
$13M
Amount sold
$6M
First sale
Jul 2017
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.1MraisedApr 2015 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard KentDirector
  • Kristopher WoodDirector
  • Thomas LaundonExecutive Officer
  • S. Edward TorresDirector
  • Steven WeinsteinDirector
  • Fred EshelmanDirector
  • William MooreExecutive Officer, Director
  • Andrew von EschenbachDirector
  • Robert SchotzingerDirector
  • Douglas ReedDirector
Offering amount
$28.1M
Amount sold
$28.1M
First sale
Apr 2015
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.